Chimerix Stock Price - CMRX

0.04 (1.25%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Small Cap Pro
Monthly Subscription
for only
DDE w/Realtime (Monthly)
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Chimerix Inc CMRX NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Close Price Last Traded
0.04 1.27% 3.19 3.12 3.275 3.25 3.15 20:00:00
Bid Price Ask Price Spread Spread % News
3.11 3.30 0.19 5.76% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3,542 553,189 $ 3.19 $ 1,764,832 1,831,134 1.19 - 4.40
Last Trade Time Type Quantity Stock Price Currency
19:33:41 formt 100 $ 3.23 USD

Chimerix Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 197.56M 61.93M 47.93M $ 12.52M $ - -1.95 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Chimerix News

Date Time Source News Article
5/28/202008:00GlobeNewswire Inc.Chimerix to Present at Jefferies Virtual Healthcare..
5/07/202008:35Edgar (US Regulatory)Quarterly Report (10-q)
5/07/202008:20Edgar (US Regulatory)Current Report Filing (8-k)
5/07/202007:00GlobeNewswire Inc.Chimerix Reports First Quarter 2020 Financial Results and..
4/29/202007:00GlobeNewswire Inc.Chimerix Announces Initiation of a Phase 2/3 Study of DSTAT..
4/28/202016:30GlobeNewswire Inc.Chimerix Receives FDA Clearance for Rolling Submission of..
4/28/202013:31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CMRX Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week3.173.553.073.23473,0840.020.63%
1 Month2.753.902.703.28978,6060.4416.0%
3 Months1.433.901.192.391,069,8001.76123.08%
6 Months2.563.901.192.23753,2090.6324.61%
1 Year3.394.401.192.23658,674-0.20-5.9%
3 Years4.865.941.192.89391,295-1.67-34.36%
5 Years41.6958.071.197.41609,395-38.50-92.35%

Chimerix Description

Chimerix Inc is a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and other serious diseases. The two clinical-stage development programs are dociparstat sodium (DSTAT) and brincidofovir (BCV). The DSTAT is a glycosaminoglycan compound derived from porcine heparin that has low anticoagulant activity but retains the ability to inhibit activities of several key proteins implicated in the retention and viability of AML blasts and leukemic stem cells in the bone marrow during chemotherapy. The BCV is an antiviral drug candidate in development as a medical countermeasure for smallpox.
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200606 11:56:18